Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
Choi JG, Winn AN, Skandari MR, Franco MI, Staab EM, Alexander J, Wan W, Zhu M, Huang ES, Philipson L, Laiteerapong N. Choi JG, et al. Among authors: winn an. Ann Intern Med. 2022 Oct;175(10):1392-1400. doi: 10.7326/M21-2941. Epub 2022 Oct 4. Ann Intern Med. 2022. PMID: 36191315 Free PMC article.
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.
Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Huang ES, et al. Diabetes Care. 2010 Jun;33(6):1269-74. doi: 10.2337/dc09-2042. Epub 2010 Mar 23. Diabetes Care. 2010. PMID: 20332354 Free PMC article. Clinical Trial.
Health utilities for children and adults with type 1 diabetes.
Lee JM, Rhee K, O'grady MJ, Basu A, Winn A, John P, Meltzer DO, Kollman C, Laffel LM, Lawrence JM, Tamborlane WV, Wysocki T, Xing D, Huang ES; JDRF Continuous Glucose Monitoring Study Group. Lee JM, et al. Med Care. 2011 Oct;49(10):924-31. doi: 10.1097/MLR.0b013e318216592c. Med Care. 2011. PMID: 21544001 Free PMC article.
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.
Alexander JT, Staab EM, Wan W, Franco M, Knitter A, Skandari MR, Bolen S, Maruthur NM, Huang ES, Philipson LH, Winn AN, Thomas CC, Zeytinoglu M, Press VG, Tung EL, Gunter K, Bindon B, Jumani S, Laiteerapong N. Alexander JT, et al. Among authors: winn an. J Gen Intern Med. 2022 Feb;37(2):415-438. doi: 10.1007/s11606-021-07105-9. Epub 2021 Sep 10. J Gen Intern Med. 2022. PMID: 34508290 Free PMC article.
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis.
Alexander JT, Staab EM, Wan W, Franco M, Knitter A, Skandari MR, Bolen S, Maruthur NM, Huang ES, Philipson LH, Winn AN, Thomas CC, Zeytinoglu M, Press VG, Tung EL, Gunter K, Bindon B, Jumani S, Laiteerapong N. Alexander JT, et al. Among authors: winn an. J Gen Intern Med. 2022 Feb;37(2):439-448. doi: 10.1007/s11606-021-07227-0. Epub 2021 Nov 30. J Gen Intern Med. 2022. PMID: 34850334 Free PMC article.
81 results